Xavier Artignan - Concepedia

Author

Xavier Artignan

Also Known As

C.H. Lannion Trestel, Venelle de Kergomar, Lannion, France, I. Juhasz-Böess, X ARTIGNAN, X Artignan, X. Artignan, Xavier Artignan

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier privé Saint Grégoire Institut Gustave Roussy Institut de Cancérologie de l'Ouest Roche (France)

About

Xavier Artignan is an author at Inserm specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	727
2	Health Sciences	7	7	548
3	Engineering	4	4	233
4	Pathology	2	2	128
5	Health Informatics	1	1	21

Xavier Artignan

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, The Lancet Oncology	2021	1.2K
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. Thierry Conroy, Najib Lamfichekh, Pierre-Luc Etienne, Journal of Clinical Oncology Surgical OncologyCancer ManagementAdjuvant ChemotherapySurgeryOncology	2020	177
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial Thierry Conroy, Florence Castan, Pierre-Luc Etienne, Annals of Oncology Surgical OncologyTotal Neoadjuvant TherapyGastrointestinal OncologyMedicineColorectal Cancer	2024	144
Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement Xavier Artignan, Monique H.P. Smitsmans, Jos V Lebesque, International Journal of Radiation OncologyBiologyPhysics Medical UltrasoundEngineeringMedical ImagingImage AcquisitionBiomedical Imaging	2004	115
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) Thomas Bachelot, Eva Ciruelos, Fabio Puglisi, Annals of Oncology Metastatic Breast CancerBreast OncologyMedicinePathologyPreliminary Safety	2019	111
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial. Thierry Conroy, Pierre-Luc Etienne, Emmanuel Rio, Journal of Clinical Oncology Surgical OncologyCancer ManagementAdjuvant ChemotherapySurgeryOncology	2023	105
Automatic localization of the prostate for on-line or off-line image-guided radiotherapy Monique H.P. Smitsmans, J. Wolthaus, Xavier Artignan, International Journal of Radiation OncologyBiologyPhysics Off-line Image-guided RadiotherapyRadiation OncologyImage AnalysisEngineeringMedical Imaging	2004	82
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer James W.F. Catto, Ben Tran, Morgan Rouprêt, Annals of Oncology	2023	67
First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX Plus<sup>125</sup>IUdR Christine Rebischung, Doreen Hoffmann, Laëtitia Stefani, International Journal of Radiation Biology	2008	50
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863 Fatma Ataman, Alfredo Zurlo, Xavier Artignan, European Journal of Cancer UrologyRadiation MedicineRadiation TherapyMedicineBrachytherapy	2004	47

Page 1